OTCM
NAFS
Market cap46mUSD
Oct 05, Last price
0.67USD
1D
0.00%
1Q
-4.79%
Jan 2017
-99.88%
IPO
-100.00%
Name
NORTH AMERICA FRAC SAND
Chart & performance
P/E
—
P/S
248.10
EPS
—
Div yield, %
—
Shrs. gr., 5y
99.99%
Rev. gr., 5y
%
Revenues
188k
+37.10%
Net income
-1m
L+28.45%
CFO
-83k
L-81.71%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating under the brand Voycare, North America Frac Sand, Inc. delivers telemedicine and medical tourism solutions within the United States. The company's primary objective is to facilitate access to healthcare for international patients, particularly focusing on Chinese individuals traveling abroad for medical purposes in North and South America. Their specialized services span areas such as oncology, in vitro fertilization, cosmetic surgery, and general wellness programs. Established in 2019, the company is headquartered in Covina, California, and also maintains an office in Shanghai, China.
Key people
Joseph A. Kistler
Chief Financial Officer, Director · since 2020
Xuemei Li
Chief Operating Officer, Secretary · since 2020
Malcolm Alexander
Director · since 2014
Edwin G. Morrow
Director · since 2016
Legal address
C/O Hunt, Clifford J, Esq.
8200 Seminole Boulevard
Seminole, FL 33772
US
8200 Seminole Boulevard
Seminole, FL 33772
US
Headquarters
8200 Seminole Boulevard
Seminole, FL 33772
US
Seminole, FL 33772
US
Previous name
Innovate Building Systems, Inc.
Previous name
New Found Shrimp, Inc.
Previous name
Xterra Building Systems, Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||